LFTSF (LifeTech Scientific) Other Current Assets: $24.2 Mil (As of Dec. 2025)


LFTSF LifeTech Scientific Corp LFTSF
96 GF Score
Price $0.23
GF Value $0.35
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific Other Current Assets?

LifeTech Scientific LFTSF 96 Other Current Assets is $24.2 Mil as of Dec. 2025. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.35. The stock has 4 warning signs investors should review.

LifeTech Scientific's other current assets for the quarter that ended in Dec. 2025 was $24.2 Mil.

LifeTech Scientific's quarterly other current assets declined from Dec. 2024 ($63.8 Mil) to Jun. 2025 ($61.1 Mil) and declined from Jun. 2025 ($61.1 Mil) to Dec. 2025 ($24.2Mil).

LifeTech Scientific's annual other current assets increased from Dec. 2023 ($62.5 Mil) to Dec. 2024 ($63.8 Mil) declined from Dec. 2024 ($63.8 Mil) to Dec. 2025 ($24.2 Mil).


LifeTech Scientific Other Current Assets Related Terms


LifeTech Scientific Other Current Assets Historical Data

* Premium members only.

The historical data trend for LifeTech Scientific's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific Other Current Assets Chart

LifeTech Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.36 21.69 62.51 63.78 24.15

LifeTech Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.51 67.39 63.78 61.06 24.15
LFTSF
96GF Score
LifeTech Scientific Corp LFTSF
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeTech Scientific Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of $24.2 Mil mean?
LifeTech Scientific (LFTSF) has a Other Current Assets of $24.2 Mil as of Dec. 2025. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on LifeTech Scientific.
Is LifeTech Scientific's Other Current Assets too high?
LifeTech Scientific's current Other Current Assets is $24.2 Mil. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Other Current Assets compare to ABT and SYK?
LifeTech Scientific's Other Current Assets of $24.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Devices & Instruments company?
A good Other Current Assets depends on the Medical Devices & Instruments industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on LifeTech Scientific. LifeTech Scientific's current Other Current Assets is $24.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Other Current Assets of $24.2 Mil. The stock's GF Value™ is $0.35, compared to a current price of $0.23 — trading 33.3% below its estimated fair value. The current Other Current Assets is $24.2 Mil. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Other Current Assets is $24.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeTech Scientific (LFTSF) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of $0.23 is trading 33.3% below its estimated GF Value™ of $0.35.

Key valuation signals for LFTSF:

  • Other Current Assets: $24.2 Mil
  • GF Value™: $0.35 vs. price of $0.23 (33.3% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score

Get the complete analysis for LFTSF

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price
$0.35
GF Value